Disposition of 5-ASa by olsalazine (Dipentum) and mesalazine (Asacol) in patients with ulcerative colitis in remission

被引:0
|
作者
Archimandritis, A
Hatzis, G
Konstandinidis, A
Paraskeva, K
Tjivras, M
Skandalis, N
机构
[1] UNIV ATHENS, LAIKO GEN HOSP,SCH MED,DEPT PATHOPHYSIOL, GASTROENTEROL SECT, ATHENS, GREECE
[2] GEN STATE HOSP ATHENS, GASTROENTEROL CLIN, ATHENS, GREECE
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A924 / A924
页数:1
相关论文
共 50 条
  • [21] Is 5-ASA Still the Treatment of Choice for Ulcerative Colitis?
    Cottone, Mario
    Renna, Sara
    Modesto, Irene
    Orlando, Ambrogio
    CURRENT DRUG TARGETS, 2011, 12 (10) : 1396 - 1405
  • [22] OLSALAZINE (DIPENTUM) AS LONG-TERM TREATMENT IN ULCERATIVE-COLITIS
    SANDBERGGERTZEN, H
    JARNEROT, G
    TYSK, C
    GASTROENTEROLOGY, 1987, 92 (05) : 1612 - 1612
  • [23] ORAL 5-AMINOSALICYLIC ACID (5-ASA) INDUCES AND MAINTAINS REMISSION IN ULCERATIVE-COLITIS
    SCHROEDER, KW
    TREMAINE, WJ
    ILSTRUP, D
    GASTROENTEROLOGY, 1987, 92 (05) : 1626 - 1626
  • [24] Efficacy and tolerability of olsalazine (Dipentum) in the treatment of patients with ulcerative colitis -: Results of a field study
    Singer, M. V.
    Schmausser, H.
    Schoenfeld, G.
    HEPATO-GASTROENTEROLOGY, 2006, 53 (69) : 317 - 321
  • [25] Colonic mucosal concentration of 5-ASA in ulcerative colitis.
    Frieri, G
    Palumbo, G
    Pimpo, MT
    Caprilli, R
    Viscido, A
    Onori, L
    Latella, G
    Pantaleoni, GC
    GASTROENTEROLOGY, 1997, 112 (04) : A975 - A975
  • [26] Clinical efficacy of different 5-ASA preparations in ulcerative colitis
    Kruis, W
    Pohl, C
    MEDIZINISCHE KLINIK, 1999, 94 : 26 - 29
  • [27] OLSALAZINE IN MAINTENANCE OF CLINICAL REMISSION IN PATIENTS WITH ULCERATIVE-COLITIS
    WRIGHT, JP
    OKEEFE, EA
    CUMING, L
    JASKIEWICZ, K
    DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (10) : 1837 - 1842
  • [28] SMOKING HISTORY DOES NOT PREDICT RESPONSE TO ORAL 5-ASA (ASACOL) TREATMENT OF MILDLY TO MODERATELY ACTIVE ULCERATIVE-COLITIS
    TREMAINE, WJ
    SANDBORN, WJ
    SCHROEDER, KW
    GASTROENTEROLOGY, 1993, 104 (04) : A791 - A791
  • [29] Cost-effectiveness of sulfasalazine vs 5-ASA in the maintenance of remission of chronic ulcerative colitis (CUC).
    Leighton, JA
    Ramzan, NN
    Pasha, TM
    GASTROENTEROLOGY, 1999, 116 (04) : A74 - A74
  • [30] Systemic absorption of 5-aminosalicylic acid in patients with inactive ulcerative colitis treated with olsalazine and mesalazine
    Tzivras, M
    Konstandinidis, A
    Hatzis, G
    Paraskeva, K
    Skandalis, N
    Archimandritis, A
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1997, 9 (07) : 729 - 730